Robert S.  Weiss net worth and biography

Robert Weiss Biography and Net Worth

Director of Cooper Companies
Mr. Weiss served as our President from March 2008 and as our Chief Executive Officer from November 2007 until his retirement in May 2018. He also served as President of CooperVision, our contact lens subsidiary, from March 2007 to February 2008. He previously served as our Chief Operating Officer from January 2005 to October 2007 and as Executive Vice President from October 1995 to October 2007. He served as our Chief Financial Officer from September 1989 to January 2005. He served as our Treasurer from 1989 to March 2002. Since joining us in 1977, he has held a number of finance positions both with us and Cooper Laboratories, Inc. (our former parent).

Mr. Weiss served as a director of Accuray Incorporated (Nasdaq: ARAY), a company that develops, manufactures, and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives, until November 2019. He served on its nominating and governance committee and on its audit committee. He also served as a member of the Board of Trustees of the University of Scranton in Pennsylvania until May 2021, including service on its finance, advancement, and audit committees.

What is Robert S. Weiss' net worth?

The estimated net worth of Robert S. Weiss is at least $25.12 million as of December 19th, 2023. Mr. Weiss owns 282,772 shares of Cooper Companies stock worth more than $25,121,464 as of April 26th. This net worth evaluation does not reflect any other assets that Mr. Weiss may own. Learn More about Robert S. Weiss' net worth.

How do I contact Robert S. Weiss?

The corporate mailing address for Mr. Weiss and other Cooper Companies executives is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. Cooper Companies can also be reached via phone at (925) 460-3600 and via email at [email protected]. Learn More on Robert S. Weiss' contact information.

Has Robert S. Weiss been buying or selling shares of Cooper Companies?

Robert S. Weiss has not been actively trading shares of Cooper Companies within the last three months. Most recently, Robert S. Weiss sold 317,480 shares of the business's stock in a transaction on Tuesday, December 19th. The shares were sold at an average price of $91.2025, for a transaction totalling $28,954,969.70. Following the completion of the sale, the director now directly owns 282,772 shares of the company's stock, valued at $25,789,513.33. Learn More on Robert S. Weiss' trading history.

Who are Cooper Companies' active insiders?

Cooper Companies' insider roster includes Brian Andrews (CFO), Robert Auerbach (CEO), Jody Lindell (Director), Daniel McBride (COO), Gary Petersmeyer (Director), Agostino Ricupati (SVP), Holly Sheffield (EVP), Gerard Warner, III (COO), Robert Weiss (Director), and Albert White, III (CEO). Learn More on Cooper Companies' active insiders.

Are insiders buying or selling shares of Cooper Companies?

In the last year, insiders at the medical device company sold shares 5 times. They sold a total of 375,004 shares worth more than $34,740,553.56. The most recent insider tranaction occured on March, 18th when CAO Agostino Ricupati sold 54,724 shares worth more than $5,521,104.36. Insiders at Cooper Companies own 2.0% of the company. Learn More about insider trades at Cooper Companies.

Information on this page was last updated on 3/18/2024.

Robert S. Weiss Insider Trading History at Cooper Companies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2023Sell317,480$91.20$28,954,969.70282,772View SEC Filing Icon  
3/7/2023Sell150,040$84.43$12,667,877.20280,000View SEC Filing Icon  
3/29/2022Sell52,156$103.81$5,414,314.36View SEC Filing Icon  
6/10/2019Sell208,624$80.94$16,884,983.44619,900View SEC Filing Icon  
3/19/2019Sell283,608$72.95$20,689,912.62468,740View SEC Filing Icon  
9/5/2018Sell234,172$63.21$14,800,841.26630,840View SEC Filing Icon  
3/12/2018Sell147,076$60.59$8,910,967.15543,744View SEC Filing Icon  
12/18/2017Sell130,000$56.18$7,302,750.00476,444View SEC Filing Icon  
6/27/2016Sell607,356$40.76$24,752,793.78802,468View SEC Filing Icon  
4/7/2015Sell270,000$46.63$12,590,100.00View SEC Filing Icon  
3/10/2015Sell264,000$45.56$12,026,520.00View SEC Filing Icon  
7/3/2014Sell484,800$36.26$17,577,636.00View SEC Filing Icon  
6/10/2013Sell343,200$30.36$10,420,410.00View SEC Filing Icon  
12/27/2012Sell204,008$23.05$4,702,384.40View SEC Filing Icon  
See Full Table

Robert S. Weiss Buying and Selling Activity at Cooper Companies

This chart shows Robert S Weiss's buying and selling at Cooper Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cooper Companies Company Overview

Cooper Companies logo
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Read More

Today's Range

Now: $88.84
Low: $88.77
High: $90.12

50 Day Range

MA: $97.52
Low: $89.86
High: $102.77

2 Week Range

Now: $88.84
Low: $75.93
High: $104.07

Volume

1,143,255 shs

Average Volume

1,092,361 shs

Market Capitalization

$17.66 billion

P/E Ratio

60.75

Dividend Yield

N/A

Beta

0.94